Join Free For Buyer|Sign In

Professional Online Trade Platform for API, Preparation and Pharmaceutical Machinery and

You are here:  Home >>  News >>  Market News >>  Shire purchase backed by Takeda shareholders

Shire purchase backed by Takeda shareholders

December 07, 2018 By pharmatimes
Tag: Shire , Takeda , US

Takeda shareholders have backed the firm’s proposed £46 billion acquisition of Shire.

Takeda announced in May this year a deal to buy the firm, after having its merger proposals previously turned down four times by Shire.

The deal has since been given the green light by the European Commission, the US Federal Trade Commission, the Japan Fair Trade Commission, the State Administration for Market Regulation in China and the Brazilian Administrative Council for Economic Defense, among other regulatory authorities.

At least 88% of shareholder votes at the extraordinary general meeting were in favour of the deal for the combined group, which is to be headquartered in Japan.

“We are delighted that our shareholders have given their strong support to our acquisition of Shire," said Takeda chief executive Christophe Weber.

“With shareholder approval secured, we are looking forward to closing the acquisition in the coming weeks."

The Financial Times said earlier this year that if successfully completed, the deal will “rank as one of the industry’s biggest, and mark a significant moment in the evolution of Japan Inc as a global dealmaker.”


Editor's Note:

To apply for becoming a contributor of,

welcome to send your CV and sample works to us,


Add a comment
Click here to Login or to Register for free. You will be taken back to your selected item after Login/Registration.
More>> MarketNews
More>> Editors’Picks
More>> TopStories
More>> HotTags
Follow Us
CPhI Online Trade Platform: Worldwide|English|中国站
Customer Service:  86-400 610 1188 (9: 00-18: 00, Mon-Fri)
About Us| Contact Us| Terms of Services| Privacy Policy| Intellectual Property Statement| Links | Site Map
Copyright 2006-20 Shanghai UBM Sinoexpo International Exhibition Co Ltd (All Rights Reserved). ICP 05034851-53
live chat